Search
Medical Xpress: High midlife stress hormone levels linked to Alzheimer’s risk in postmenopausal women
News4 (WOAI TV)/FoxSA (KABB TV): San Antonio experts highlight early intervention as key in Alzheimer’s awareness month
Texas Public Radio (KSTX): San Antonio researcher finds that cholesterol levels may predict Alzheimer’s risk
Texas Public Radio: A non-opioid painkiller has hit the market, and a San Antonio doctor calls it a game-changer
Funds to develop transformative technologies not currently available in Texas Contact: Steven Lee, 210-450-3823, lees22@uthscsa.edu Content provided by Jane Alvarez-Hernandez SAN ANTONIO, June 18, 2025 – The University of Texas Health Science Center at San Antonio (UT Health San Antonio) is taking the lead in targeting hard-to-treat cancers and boosting vaccination rates for the human…
Contact: Eileen Teves, 210-450-7239, tevese@uthscsa.edu Content provided by Claire Kowalick SAN ANTONIO, June 18, 2025 – Approximately one in 300 Americans have a mutation in the BRCA1 or BRCA2 gene, which helps repair damaged DNA, putting them at a higher risk of developing certain cancers, especially breast, prostate and ovarian cancer. Many patients with these cancers […]
Science Magazine: CPRIT Grants UT Health San Antonio $3.4 Million to Combat Drug-Resistant Cancers and Boost HPV Vaccination Rates
Daohong Zhou, MD, tenured professor in the Department of Biochemistry and Structural Biology, and Erika L. Thompson, PhD, MPH, Department of Quantitative and Qualitative Health Sciences, were interviewed for this article. Read More
In a multi-institutional study published in Science Direct, researchers revealed that testing urine-based tumor DNA (utDNA) can help predict which bladder cancer patients are at higher risk for recurrence after treatment. This study analyzed utDNA from patients in the SWOG S1605 trial, who were treated with atezolizumab, an immunotherapy drug. Researchers used the UroAmp test to examine […]
Science Magazine: UT Health San Antonio Scientists Uncover Key Mechanisms Behind Cancer Drug Resistance